...
首页> 外文期刊>Translational research: the journal of laboratory and clinical medicine >Microbiota reprogramming for treatment of alcohol-related liver disease
【24h】

Microbiota reprogramming for treatment of alcohol-related liver disease

机译:Microbiota重新编程用于治疗酒精相关肝病

获取原文
获取原文并翻译 | 示例
           

摘要

In the past decade knowledge has expanded regarding the importance of the gut microbiota in maintaining intestinal homeostasis and overall health. During this same time, we have also gained appreciation for the role of the gut-liver axis in the development of liver diseases. Alcohol overconsumption is one of the leading causes of liver failure globally. However, not all people with alcohol use disorder progress to advanced stages of liver disease. With advances in technology to investigate the gut microbiome and metabolome, we are now beginning to delineate alcohol's effects on the gut microbiome in relation to liver disease. This review presents our current understanding on the role of the gut microbiota during alcohol exposure, and various therapeutic attempts that have been made to reprogram the gut microbiota with the goal of alleviating alcoholic-related liver disease.
机译:在过去的十年里,关于肠道微生物群在维持肠道内环境稳定和整体健康方面的重要性的知识已经扩展。在此期间,我们还认识到肠肝轴在肝脏疾病发展中的作用。酗酒是全球肝衰竭的主要原因之一。然而,并非所有酒精使用障碍患者都会发展到肝病的晚期。随着研究肠道微生物组和代谢组的技术进步,我们现在开始描述酒精对肝脏疾病相关肠道微生物组的影响。本综述介绍了我们目前对酒精暴露期间肠道微生物群作用的理解,以及为减轻酒精相关肝病而对肠道微生物群进行重组的各种治疗尝试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号